Align Technology, Inc. (NASDAQ: ALGN) shares closed at USD 131.50, marking a decrease of 0.67 points or approximately 0.51% during the latest trading session. The move comes as part of a broader period of market volatility in the medical devices sector. Investors are closely watching the company’s price movements, market position, and operational outlook.
In this article:
- Company Overview
- Stock Performance
- Market Position and Sector
- Governance and Leadership
- Key Financial Data
- FAQ
- Conclusion
- Disclaimer
- Official Announcement
Company Overview
Align Technology, Inc. is a US-based medical device company incorporated in 1997 and headquartered in Tempe, Arizona. The company designs, manufactures, and markets the Invisalign clear aligner system along with iTero intraoral scanners. It operates through two main segments: Clear Aligner and Scanners and Services. Products range from comprehensive orthodontic solutions for teenage patients to non-case products like retainers and cleaning materials for dental professionals. The company’s international presence includes operations in the United States, Switzerland, China, and other global markets.
Stock Performance
As of the latest market close, Align Technology shares traded at USD 131.50. This represents a decrease of 0.67 points, or approximately 0.51% compared to the previous trading day. The stock has moved within a 52-week range of USD 122.00 to USD 246.19, indicating significant historical volatility. Trading volume reached 1,477,511 shares, which is slightly below its average daily volume of 1,585,242 shares.
For investors, monitoring such metrics helps in assessing liquidity and potential price movement. Price changes, when analyzed alongside historical ranges, may signal market sentiment or sector-specific pressures.
Market Position and Sector
Align Technology holds a prominent position in the “Medical – Devices” industry within the healthcare sector. This sector often benefits from consistent demand due to the essential nature of dental and orthodontic services. The company’s global footprint and market share in clear aligners provide a competitive edge, supported by proprietary technology and a recognized brand in orthodontics.
Governance and Leadership
Joseph M. Hogan currently serves as CEO, overseeing a workforce of approximately 21,200 full-time employees. Leadership plays a pivotal role in maintaining operational efficiency, market expansion, and investor confidence. Hogan’s tenure emphasizes strategic product development and the integration of digital technologies into dental practices globally.
Key Financial Data
Align Technology’s market capitalization stands at approximately USD 9.53 billion, positioning it among mid-to-large cap companies in its sector. The company does not currently pay dividends, which may indicate a preference for reinvestment into growth and R&D. For income-focused investors, the absence of dividends requires a focus on capital appreciation strategies.
Key identifiers for trading include:
- ISIN: US0162551016
- CUSIP: 016255101
- Exchange: NASDAQ Global Select Market
- CIK: 0001097149
These identifiers help in ensuring clarity in transactions and holdings across markets.
FAQ
- Does Align Technology pay dividends? No, the company does not currently issue dividends.
- On which exchange is Align Technology traded? NASDAQ Global Select Market under the ticker ALGN.
- How many employees does the company have? Approximately 21,200 full-time employees.
- What is the 52-week range of the stock? USD 122.00 to USD 246.19.
- Who is the CEO? Joseph M. Hogan.
Conclusion
Align Technology remains a notable player in the medical devices sector with strong brand recognition and diversified offerings. While the recent share price movement was minor, the overall performance will continue to depend on product adoption, global market dynamics, and sector health. Investors should weigh market cap, liquidity metrics, and operational strategies when considering exposure.
Disclaimer
This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence before making investment decisions.
Official Announcement
For full information about the company, see the link below.